One of the most commonly used is flow cytometry (FCM) employing CSC-specific cell surface markers, like CD133 and CD44, and the ALDH1A1, which is the most used and described marker for lung cancer stem cells (67). The gene discussed is CD44; the disease is lung carcinoma.